Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study

Cutis. 2024 Jun;113(6):251-254. doi: 10.12788/cutis.1027.

Abstract

Inpatient hospitalization of individuals with hidradenitis suppurativa (HS) has increased. Inpatient services may not be familiar enough with this disease to understand how to manage severe HS and/or HS flares. It would be beneficial to the inpatient medical community to establish consensus recommendations on holistic inpatient care of patients with HS. A survey study was developed and distributed by Wake Forest University School of Medicine (Winston-Salem, North Carolina). A total of 26 dermatologists participated in the Delphi process, and the process was conducted in 2 rounds. Participants voted on proposal statements using a 9-point scale (1=very inappropriate; 9=very appropriate). Statements were developed using current published guidelines for management of HS and supportive care guidelines for other severe inpatient dermatologic diseases. A total of 50 statements were reviewed and voted on between the 2 rounds. Consensus was determined using the RAND/UCLA Appropriateness Method. Twenty-six dermatologists completed the first-round survey, and 24 completed the second-round survey. The 40 consensus recommendations generated through these surveys can serve as a resource for providers caring for inpatients with HS.

MeSH terms

  • Consensus*
  • Delphi Technique*
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / therapy
  • Hospitalization*
  • Humans
  • Inpatients
  • Surveys and Questionnaires